175 related articles for article (PubMed ID: 37739247)
21. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
[TBL] [Abstract][Full Text] [Related]
22. Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
Shen C; Zhang DL; Cheng XL; Zhang WC; Zhao JJ
Urol Int; 2023; 107(9):841-847. PubMed ID: 37769625
[TBL] [Abstract][Full Text] [Related]
23. Tertiary lymphoid structures in cancer.
Schumacher TN; Thommen DS
Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
[TBL] [Abstract][Full Text] [Related]
24. Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.
Kang W; Feng Z; Luo J; He Z; Liu J; Wu J; Rong P
Front Immunol; 2021; 12():689270. PubMed ID: 34394083
[TBL] [Abstract][Full Text] [Related]
25. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance.
Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934
[TBL] [Abstract][Full Text] [Related]
26. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
Front Immunol; 2022; 13():962056. PubMed ID: 36189233
[TBL] [Abstract][Full Text] [Related]
27. A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy.
Li X; Wan Z; Liu X; Ou K; Yang L
Med Oncol; 2022 Jan; 39(4):43. PubMed ID: 35092511
[TBL] [Abstract][Full Text] [Related]
28. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
29. Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
Hayashi Y; Makino T; Sato E; Ohshima K; Nogi Y; Kanemura T; Honma K; Yamashita K; Saito T; Tanaka K; Yamamoto K; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Wada H; Morii E; Eguchi H; Doki Y
Br J Cancer; 2023 Jun; 128(12):2175-2185. PubMed ID: 37016103
[TBL] [Abstract][Full Text] [Related]
30. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies.
Zhao H; Wang H; Zhou Q; Ren X
Cancer Biol Med; 2021 Sep; 18(4):981-91. PubMed ID: 34553849
[TBL] [Abstract][Full Text] [Related]
31. Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer.
Zhou L; Xu B; Liu Y; Wang Z
Oncoimmunology; 2021 May; 10(1):1915574. PubMed ID: 34104539
[TBL] [Abstract][Full Text] [Related]
32. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
[TBL] [Abstract][Full Text] [Related]
33. Development and Validation of a Machine Learning Model for Detection and Classification of Tertiary Lymphoid Structures in Gastrointestinal Cancers.
Li Z; Jiang Y; Li B; Han Z; Shen J; Xia Y; Li R
JAMA Netw Open; 2023 Jan; 6(1):e2252553. PubMed ID: 36692877
[TBL] [Abstract][Full Text] [Related]
34. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling.
Johansson-Percival A; Ganss R
Front Immunol; 2021; 12():674375. PubMed ID: 34122434
[TBL] [Abstract][Full Text] [Related]
36. Detection and quantitative analysis of tumor-associated tertiary lymphoid structures.
Yang M; Che Y; Li K; Fang Z; Li S; Wang M; Zhang Y; Xu Z; Luo L; Wu C; Lai X; Wang W
J Zhejiang Univ Sci B; 2023 Sept 15; 24(9):779-795. PubMed ID: 37701955
[TBL] [Abstract][Full Text] [Related]
37. Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy.
Zhang K; Xie X; Zheng SL; Deng YR; Liao D; Yan HC; Kang X; Jiang HP; Guo SQ
Front Oncol; 2023; 13():1276907. PubMed ID: 38023214
[TBL] [Abstract][Full Text] [Related]
38. Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma.
Li R; Huang X; Yang W; Wang J; Liang Y; Zhang T; Mao Q; Xia W; Xu L; Xu X; Dong G; Jiang F
J Pathol Clin Res; 2022 Sep; 8(5):422-435. PubMed ID: 35711130
[TBL] [Abstract][Full Text] [Related]
39. Turning Tertiary Lymphoid Structures (TLS) into Hot Spots: Values of TLS in Gastrointestinal Tumors.
Cai D; Yu H; Wang X; Mao Y; Liang M; Lu X; Shen X; Guan W
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672316
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J
Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
